Back to the library
Growth hormone signaling
Ipamorelin
PreclinicalResearch education only. This profile does not establish benefits or safety for personal use.
EvidencePreclinical
Curated studies1
Research areaGrowth hormone signaling
At a glance
A growth hormone secretagogue characterized in preclinical pharmacology studies.
How it is studied
The linked paper measures growth hormone release and selectivity in laboratory models.
Evidence & studies 1 curated
Read the population, methods, and limitations alongside each outcome. This selection is a starting point, not a systematic review.
Animal & cell study · 1998Ipamorelin, the first selective growth hormone secretagogue
Read summary & limitationsRisks & limits
- Clinical benefit and long-term safety are not established by the evidence curated here.
- Identity, purity, formulation, and route affect risk; a research label is not evidence of suitability for human use.
No universal storage, reconstitution, or administration protocol is provided. Product-specific instructions and evidence must be established separately.